Mesenchymal stem cell fate following non-viral gene transfection strongly depends on the choice of delivery vector

T. Gonzalez Fernandez, B.N. Sathy, C. Hobbs, G.M. Cunniffe, H.O. McCarthy, N.J. Dunne, V. Nicolosi, F.J. O'Brien, D.J. Kelly

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

Controlling the phenotype of mesenchymal stem cells (MSCs) through the delivery of regulatory genes is a promising strategy in tissue engineering (TE). Essential to effective gene delivery is the choice of gene carrier. Non-viral delivery vectors have been extensively used in TE, however their intrinsic effects on MSC differentiation remain poorly understood. The objective of this study was to investigate the influence of three different classes of non-viral gene delivery vectors: (1) cationic polymers (polyethylenimine, PEI), (2) inorganic nanoparticles (nanohydroxyapatite, nHA) and (3) amphipathic peptides (RALA peptide) on modulating stem cell fate after reporter and therapeutic gene delivery. Despite facilitating similar reporter gene transfection efficiencies, these nanoparticle-based vectors had dramatically different effects on MSC viability, cytoskeletal morphology and differentiation. After reporter gene delivery (pGFP or pLUC), the nHA and RALA vectors supported an elongated MSC morphology, actin stress fibre formation and the development of mature focal adhesions, while cells appeared rounded and less tense following PEI transfection. These changes in MSC morphology correlated with enhanced osteogenesis following nHA and RALA transfection and adipogenesis following PEI transfection. When therapeutic genes encoding for transforming growth factor beta 3 (TGF-β3) and/or bone morphogenic protein 2 (BMP2) were delivered to MSCs, nHA promoted osteogenesis in 2D culture and the development of an endochondral phenotype in 3D culture, while RALA was less osteogenic and appeared to promote a more stable hyaline cartilage-like phenotype. In contrast, PEI failed to induce robust osteogenesis or chondrogenesis of MSCs, despite effective therapeutic protein production. Taken together, these results demonstrate that the differentiation of MSCs through the application of non-viral gene delivery strategies depends not only on the gene delivered, but also on the gene carrier itself.
Original languageEnglish
Pages (from-to)226-238
JournalActa Biomaterialia
Volume55
Early online date29 Mar 2017
DOIs
Publication statusPublished - Jun 2017

Fingerprint Dive into the research topics of 'Mesenchymal stem cell fate following non-viral gene transfection strongly depends on the choice of delivery vector'. Together they form a unique fingerprint.

Cite this